8-11-14-eicosatrienoic-acid and Lymphoma--Mantle-Cell

8-11-14-eicosatrienoic-acid has been researched along with Lymphoma--Mantle-Cell* in 1 studies

Other Studies

1 other study(ies) available for 8-11-14-eicosatrienoic-acid and Lymphoma--Mantle-Cell

Article	Year
The effects on plasma, red cell and platelet fatty acids of taking 12 g/day of ethyl-eicosapentaenoate for 16 months: dihomogammalinolenic, arachidonic and docosahexaenoic acids and relevance to Inuit metabolism. Prostaglandins, leukotrienes, and essential fatty acids, 2003, Volume: 68, Issue:5 A patient with mantle cell lymphoma took 12g/day of ethyl-eicosapentaenoate for 16 months. Compared to reference values, eicosapentaenoic and docosapentaenoic acids were elevated in plasma, red cells and platelets but docosahexaenoic acid levels were in the normal range. Arachidonic acid levels were moderately reduced but dihomogammalinolenic acid levels remained in the normal range. In spite of a long chain n-3 fatty acid intake higher than in most Inuit populations, arachidonic acid levels remained considerably higher in this patient than in the Inuit. The implications for understanding of fatty acid metabolism in humans are discussed. Topics: 8,11,14-Eicosatrienoic Acid; Arachidonic Acid; Blood Platelets; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Eicosapentaenoic Acid; Erythrocytes; Fatty Acids; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Platelet Aggregation Inhibitors; Time Factors	2003

Article

Year

The effects on plasma, red cell and platelet fatty acids of taking 12 g/day of ethyl-eicosapentaenoate for 16 months: dihomogammalinolenic, arachidonic and docosahexaenoic acids and relevance to Inuit metabolism.

Prostaglandins, leukotrienes, and essential fatty acids, 2003, Volume: 68, Issue:5

A patient with mantle cell lymphoma took 12g/day of ethyl-eicosapentaenoate for 16 months. Compared to reference values, eicosapentaenoic and docosapentaenoic acids were elevated in plasma, red cells and platelets but docosahexaenoic acid levels were in the normal range. Arachidonic acid levels were moderately reduced but dihomogammalinolenic acid levels remained in the normal range. In spite of a long chain n-3 fatty acid intake higher than in most Inuit populations, arachidonic acid levels remained considerably higher in this patient than in the Inuit. The implications for understanding of fatty acid metabolism in humans are discussed.

Topics: 8,11,14-Eicosatrienoic Acid; Arachidonic Acid; Blood Platelets; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Eicosapentaenoic Acid; Erythrocytes; Fatty Acids; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Platelet Aggregation Inhibitors; Time Factors

2003